{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:22:47Z","timestamp":1790713367248,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fondation Gustave Roussy"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejca.2018.08.003","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T13:39:26Z","timestamp":1536932366000},"page":"108-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?"],"prefix":"10.1016","volume":"103","author":[{"given":"Clara","family":"Prud'homme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9deric","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Allorant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Yevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Ngo-Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Nicotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-2968","authenticated-orcid":false,"given":"Stefan","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"De Baere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-6293","authenticated-orcid":false,"given":"Lambros","family":"Tselikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejca.2018.08.003_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.breast.2005.08.004","article-title":"Adjuvant chemotherapy in 2005: standards and beyond","volume":"14","author":"Piccart","year":"2005","journal-title":"Breast"},{"issue":"5676","key":"10.1016\/j.ejca.2018.08.003_bib2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.ejca.2018.08.003_bib3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejca.2018.08.003_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.ejca.2018.08.003_bib6","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1200\/JCO.2009.26.5983","article-title":"Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers","volume":"28","author":"Von Hoff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2018.08.003_bib7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2012.06.014","article-title":"Array CGH and PIK3CA\/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer","volume":"48","author":"Arnedos","year":"2012","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.ejca.2018.08.003_bib8","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-12-1627","article-title":"Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative","volume":"18","author":"Tsimberidou","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejca.2018.08.003_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jamaoncol.2015.1313","article-title":"Whole-exome sequencing of metastatic cancer and biomarkers of treatment response","volume":"1","author":"Beltran","year":"2015","journal-title":"JAMA Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2018.08.003_bib10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","article-title":"Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial","volume":"16","author":"Le Tourneau","year":"2015","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2018.08.003_bib11","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1158\/0008-5472.CAN-15-3043","article-title":"Cancer therapy directed by comprehensive genomic profiling: a single center study","volume":"76","author":"Wheler","year":"2016","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ejca.2018.08.003_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jvir.2013.04.019","article-title":"Personalized oncology in interventional radiology","volume":"24","author":"Abi-Jaoudeh","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.ejca.2018.08.003_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/2159-8290.CD-16-1396","article-title":"High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial","volume":"7","author":"Massard","year":"2017","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.ejca.2018.08.003_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/gim.2016.174","article-title":"The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial","volume":"19","author":"Pages","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.ejca.2018.08.003_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejca.2016.02.006","article-title":"Factors associated with success of image-guided tumour biopsies: results from a prospective molecular triage study (MOSCATO-01)","volume":"59","author":"Tacher","year":"2016","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2018.08.003_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","article-title":"Cirse quality assurance document and standards for classification of complications: the cirse classification system","volume":"40","author":"Filippiadis","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2012.43.1718","article-title":"Use of research biopsies in clinical trials: are risks and benefits adequately discussed?","volume":"31","author":"Overman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2018.08.003_bib18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/annonc\/mdr383","article-title":"Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety","volume":"23","author":"Gomez-Roca","year":"2012","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2018.08.003_bib19","doi-asserted-by":"crossref","first-page":"W678","DOI":"10.2214\/AJR.10.4659","article-title":"Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management","volume":"196","author":"Wu","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ejca.2018.08.003_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.RVI.0000124951.24134.50","article-title":"Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients","volume":"15","author":"Covey","year":"2004","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"10.1016\/j.ejca.2018.08.003_bib21","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s00330-008-0893-1","article-title":"Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy","volume":"18","author":"Khan","year":"2008","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.ejca.2018.08.003_bib22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1378\/chest.126.3.748","article-title":"Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies","volume":"126","author":"Yeow","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ejca.2018.08.003_bib23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2214\/AJR.09.3224","article-title":"Incidence of and risk factors for pneumothorax and chest tube placement after CT fluoroscopy-guided percutaneous lung biopsy: retrospective analysis of the procedures conducted over a 9-year period","volume":"194","author":"Hiraki","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2018.08.003_bib24","first-page":"S99","article-title":"Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance","volume":"6","author":"Boskovic","year":"2014","journal-title":"J Thorac Dis"},{"issue":"24","key":"10.1016\/j.ejca.2018.08.003_bib25","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.2008.16.9896","article-title":"Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations","volume":"26","author":"Brown","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.08.003_bib26","first-page":"170347","article-title":"Feasibility and safety of intrathoracic biopsy and repeat biopsy for evaluation of programmed cell death Ligand-1 expression for immunotherapy in non-small cell lung cancer","author":"Tsai","year":"2017","journal-title":"Radiology"},{"issue":"7\u20138","key":"10.1016\/j.ejca.2018.08.003_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00508-018-1317-0","article-title":"Complications of CT-guided transthoracic lung biopsy : a short report on current literature and a case of systemic air embolism","volume":"130","author":"Lang","year":"2018","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191590","article-title":"Diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: a systematic review and meta-analysis","volume":"13","author":"Han","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00330-016-4357-8","article-title":"Complication rates of CT-guided transthoracic lung\u00a0biopsy: meta-analysis","volume":"27","author":"Heerink","year":"2017","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.ejca.2018.08.003_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.rcl.2018.01.001","article-title":"Lung cancer biopsies","volume":"56","author":"Sharma","year":"2018","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib31","first-page":"150","article-title":"3rd. Digital subtraction angiography in the evaluation of renal vascular hypertension in children","volume":"81","author":"Tonkin","year":"1988","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.ejca.2018.08.003_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","article-title":"Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial","volume":"8","author":"Seeff","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2018.08.003_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-230X-12-173","article-title":"Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years","volume":"12","author":"Mueller","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejca.2018.08.003_bib34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"American association for the study of liver D. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejca.2018.08.003_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.mayocp.2015.11.015","article-title":"Incidence and risk factors for adverse events related to image-guided liver biopsy","volume":"91","author":"Boyum","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.ejca.2018.08.003_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1590\/0100-3984.2017.0011","article-title":"Injecting hemostatic matrix in the path of biopsies: efficacy, potential complications, and the management of such complications","volume":"51","author":"Rahal Junior","year":"2018","journal-title":"Radiol Bras"},{"key":"10.1016\/j.ejca.2018.08.003_bib37","article-title":"Incidence of major hemorrhage after aggressive image-guided liver mass biopsy in the era of individualized medicine","author":"Boyum","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib38","first-page":"5","article-title":"Complications of ultrasound-guided liver biopsies in dogs and cats","volume":"46","author":"Moritz","year":"2018","journal-title":"Tierarztl Prax Ausg K Kleintiere Heimtiere"},{"issue":"5","key":"10.1016\/j.ejca.2018.08.003_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MPG.0b013e3182a0e0d8","article-title":"Percutaneous liver biopsy: pathologic diagnosis and complications in children","volume":"57","author":"Short","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.ejca.2018.08.003_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2214\/AJR.17.18726","article-title":"Bleeding complications after percutaneous liver biopsy: do subcapsular lesions pose a higher risk?","volume":"211","author":"Potretzke","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ejca.2018.08.003_bib41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MPG.0b013e3182a0c7a5","article-title":"Effect of operator experience and frequency of procedure performance on complication rate after ultrasound-guided percutaneous liver biopsies","volume":"57","author":"Westheim","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"10.1016\/j.ejca.2018.08.003_bib42","first-page":"1621","article-title":"Complications and risk factors of a large series of percutaneous liver biopsies in patients with liver transplantation or liver disease","volume":"19","author":"Filingeri","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918311146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918311146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:23:16Z","timestamp":1760732596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918311146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":42,"alternative-id":["S0959804918311146"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.08.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}